Efficacy and Safety of Tiotropium in Patients With COPD and Concomitant Diagnosis of Asthma

PHASE4CompletedINTERVENTIONAL
Enrollment

472

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions
Pulmonary Disease, Chronic ObstructiveAsthma
Interventions
DRUG

Tiotropium inhalation capsules

DRUG

Placebo inhalation capsules

Trial Locations (68)

1090

A.Z. VUB, Brussels

2200

St. Elisabethziekenhuis, Herentals

2300

Sint-Elisabethziekenhuis, Turnhout

2400

H:S Bispebjerg Hospital, K?benhavn NV

2900

Lungemedicinsk afdeling Y, Hellerup

3400

Medicinsk afdeling B0642, Hiller?d

3500

Boehringer Ingelheim Investigational Site, Hasselt

3600

Boehringer Ingelheim Investigational Site, Genk

4001

Boehringer Ingelheim Investigational Site, Durban

4031

CHU Sart Tilman, Angleur

4960

Clinique Reine Astrid, Malmedy

5000

Lungemedicinsk Forskning, Odense C

6529

Boehringer Ingelheim Investigational Site, George

7130

Boehringer Ingelheim Investigational Site, Somerset West

7530

Boehringer Ingelheim Investigational Site, Bellville

7646

Boehringer Ingelheim Investigational Site, Paarl

7700

Boehringer Ingelheim Investigational Site, Cape Town

8001

Boehringer Ingelheim Investigational Site, Cape Town

12203

Boehringer Ingelheim Investigational Site, Berlin

12687

Boehringer Ingelheim Investigational Site, Berlin

13291

Hopital Ambroise Pare, Marseille

14057

MEDARS GmbH, Berlin

15562

Boehringer Ingelheim Investigational Site, Rudersdorf

16132

A.O. S. Martino e Cliniche Universitarie di Genova, Genova

Universita di Genova, Genova

20535

Pneumologisches Forschungsinstitut GmbH am Krankenhaus, Hamburg

32423

Boehringer Ingelheim Investigational Site, Minden

34070

Boehringer Ingelheim Investigational Site, Montpellier

34295

Hopital Arnaud de Villeneuve, Montpellier

44000

Boehringer Ingelheim Investigational Site, Nantes

Centre Medical Erdre St Augustin, Nantes

44100

A. O. Universitaria di Ferrara - Arcispedale S. Anna, Ferrara

50924

Med. Einrichtung der Universitat zu Koln, Cologne

51092

Hopital Maison blanche, Reims

53119

Boehringer Ingelheim Investigational Site, Bonn

56100

A.O. Pisana, Pisa

57038

Hopital Notre Dame de Bon Secours, Metz

60323

Boehringer Ingelheim Investigational Site, Frankfurt am Main

63003

Hopital Gabriel Montpied, Clermont-Ferrand

63571

Boehringer Ingelheim Investigational Site, Gelnhausen

66400

Boehringer Ingelheim Investigational Site, Chamalières

74000

Hopital d'Annecy, Annecy

80335

Boehringer Ingelheim Investigational Site, München

82131

Inamed Research GmbH & Co. KG, Gauting

90762

Boehringer Ingelheim Investigational Site, Fürth

92166

Hopital Prive Antony, Antony

V5Z 1L8

VGH Research Pavillion, Vancouver

R2H 2A6

BG 034, Room C2027, Winnipeg

L8N 3Z5

Department of Medicine, Health Sciences Centre, Hamilton

L5B 1N1

Boehringer Ingelheim Investigational Site, Mississauga

M5S 2A5

Boehringer Ingelheim Investigational Site, Toronto

M5T 2S8

Respiratory Research Lab, Toronto

M6H 3M2

Boehringer Ingelheim Investigational Site, Toronto

M6M 2J5

Department of Respiratory Medicine, Toronto

J1H 5N4

Centre de Recherche Clinique -CUSE, Sherbrooke

G1V 4G5

Hopital Laval, Ste-Foy

DK-8000

Lungemedicinsk Forskning 2B, Aarhus

DK-2650

Lungemedicinsk Klinik, Hvidovre

06000

Boehringer Ingelheim Investigational Site, Nice

02826

ClinPharm Internat. GmbH & Co. KG, Görlitz

7609 PP

Ziekenhuisgroep Twent, Almelo

4819 EV

Amphia ziekenhuis, Breda

6419 PC

Atrium medisch centrum, Heerlen

7555 DL

Ziekenhuigroep Twente, Hengelo

8934 AD

Medisch Centrum Leeuwarden, Leeuwarden

8601 ZK

Antonius Ziekenhuis, Sneek

5505 DB

Maxima Medisch Centrum, Velthoven

0001

Boehringer Ingelheim Investigational Site, Pretoria

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00152984 - Efficacy and Safety of Tiotropium in Patients With COPD and Concomitant Diagnosis of Asthma | Biotech Hunter | Biotech Hunter